Results of an innovative clinical trial led by Perth researchers have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with ...

May 15 (UPI) --Treatment with the hepatitis drug interferon-alpha-2b might speed recovery for people with COVID-19, a small study published Friday by the journal Frontiers in Immunology found.

Spectrum Pharmaceuticals has acquired an early-phase anti-CD20 cancer asset from ImmunGene as part of a broader deal. The agreement gives Spectrum an antibody-interferon fusion technology drug ...

Interferons are a category of organically rising enzymes that are created by nucleus less cells and mainly exhibit activities alongside viral inflammations and other organic inducers. The three main ...

Interferon therapies are well established as treatment options for some types of cancer, but they have not been used to treat cancers characterized by the overproduction of blood cells. The FDA has ...

A one-time shot with an experimental drug halved COVID-19 patients' risk of being hospitalized with the illness compared with a placebo, a late-stage trial shows. However, the treatment may still be ...

A new drug quashes all coronavirus variants. But regulatory hurdles and a lack of funding make it unlikely to reach the U.S. market anytime soon. By Benjamin Mueller Over the past year, America’s ...

(Tuesday, March 21, 2017 -- Toronto) -- A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola ...

This is the crystal structure of human STING, bond with a synthetic a drug currently in clinical trials for cancer. The same drug stops SARS-Cov-2 from infecting and killing susceptible animals, and I ...

A small study of an inhaled form of a commonly available drug, interferon beta, suggests it could reduce the odds of patients becoming severely ill. By Benjamin Mueller LONDON — A British drug company ...

Multiple sclerosis (MS) is a chronic demyelinating disease of the CNS. Between 1987 and 1997, clinical trials of three preparations of recombinant interferon-β were conducted in patients with MS, ...